The Aspergillus fumigatus dihydroxyacid dehydratase Ilv3A/IlvC is required for full virulence

Dihydroxyacid dehydratase (DHAD) is a key enzyme in the branched-chain amino acid biosynthetic pathway that exists in a variety of organisms, including fungi, plants and bacteria, but not humans. In this study we identified four putative DHAD genes from the filamentous fungus Aspergillus fumigatus b...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 7; no. 9; p. e43559
Main Authors Oliver, Jason D, Kaye, Sarah J, Tuckwell, Danny, Johns, Anna E, Macdonald, Darel A, Livermore, Joanne, Warn, Peter A, Birch, Mike, Bromley, Michael J
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 18.09.2012
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Dihydroxyacid dehydratase (DHAD) is a key enzyme in the branched-chain amino acid biosynthetic pathway that exists in a variety of organisms, including fungi, plants and bacteria, but not humans. In this study we identified four putative DHAD genes from the filamentous fungus Aspergillus fumigatus by homology to Saccharomyces cerevisiae ILV3. Two of these genes, AFUA_2G14210 and AFUA_1G03550, initially designated AfIlv3A and AfIlv3B for this study, clustered in the same group as S. cerevisiae ILV3 following phylogenetic analysis. To investigate the functions of these genes, AfIlv3A and AfIlv3B were knocked out in A. fumigatus. Deletion of AfIlv3B gave no apparent phenotype whereas the Δilv3A strain required supplementation with isoleucine and valine for growth. Thus, AfIlv3A is required for branched-chain amino acid synthesis in A. fumigatus. A recombinant AfIlv3A protein derived from AFUA_2G14210 was shown to have DHAD activity in an in vitro assay, confirming that AfIlv3A is a DHAD. In addition we show that mutants lacking AfIlv3A and ilv3B exhibit reduced levels of virulence in murine infection models, emphasising the importance of branched-chain amino acid biosynthesis in fungal infections, and hence the potential of targeting this pathway with antifungal agents. Here we propose that AfIlv3A/AFUA_2G2410 be named ilvC.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Conceived and designed the experiments: MJB DT PAW MB JDO AEJ. Performed the experiments: MJB SJK DT PAW JL JDO AEJ DAM. Analyzed the data: MJB SJK DT PAW MB JDO AEJ. Wrote the paper: MJB SJK DT PAW MB JDO AEJ.
Competing Interests: The authors have read the journal's policy and have the following conflicts: Jason D. Oliver and Mike Birch are current employees and Sarah J. Kaye, Danny Tuckwell, and Michael J. Bromley are former employees of F2G Limited. Michael Bromley currently has a PhD student funded in part by F2G Limited. Peter Warn acts as a consultant to F2G Limited. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0043559